Benzinga | Jul 16, 2020 07:23AM EDT

Raymond James Initiates Coverage On Arcturus Therapeutics with Outperform Rating, Announces Price Target of $72

Raymond James initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Outperform rating and announces Price Target of $72.